EAGLE GLOBAL ADVISORS LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 336 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
EAGLE GLOBAL ADVISORS LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2021$2,865,000
-2.0%
156,897
-2.3%
0.21%
-7.8%
Q4 2020$2,923,000
-4.3%
160,586
-6.2%
0.23%
-16.4%
Q3 2020$3,054,000
-1.4%
171,202
-0.9%
0.28%
-1.8%
Q2 2020$3,097,000
+13.7%
172,715
-3.8%
0.28%
+1.4%
Q1 2020$2,724,000
-26.4%
179,464
-4.3%
0.28%
+47.6%
Q4 2019$3,701,000
+75.7%
187,565
+53.2%
0.19%
+107.8%
Q3 2019$2,106,000
-12.9%
122,440
-10.3%
0.09%
-7.2%
Q2 2019$2,417,000
+13.4%
136,544
+30.4%
0.10%
+16.9%
Q1 2019$2,132,000104,6720.08%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Y.D. More Investments Ltd 1,498,811$24,700,3805.57%
TFG Asset Management GP Ltd 1,903,662$31,372,3504.20%
Clean Yield Group 542,342$8,937,7963.81%
MANAGED ASSET PORTFOLIOS, LLC 1,467,952$24,1923.67%
Mondrian Investment Partners LTD 4,081,715$67,266,6631.48%
Sippican Capital Advisors 82,235$1,355,2331.30%
Psagot Value Holdings Ltd. / (Israel) 174,300$2,8301.18%
Clal Insurance Enterprises Holdings Ltd 4,365,500$71,9431.08%
Legacy Wealth Asset Management, LLC 123,303$2,032,0330.73%
BRANDES INVESTMENT PARTNERS, LP 1,817,972$29,960,1750.64%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders